A new knee-surgery device investigated by University of Missouri-Columbia researchers that will help to repair meniscus tears, which were previously defined as irreparable, has been approved by the FDA for use in humans.
Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the Oct. 3 issue of JAMA.
Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,092,031 Phase II Small Business Innovation Grant (SBIR) from the National Eye Institute of the National Institutes of Health (NIH) to develop zebrafish eye disease models for drug screening. The grant for “New Models for Eye Diseases” will support the Phylonix program over a period of three years.
Several new studies suggest how transplant surgeons can make more effective use of kidneys from deceased donors — even those that are at the outer limits of acceptance criteria — according to researchers from Wake Forest University Baptist Medical Center.
The American College of Physicians and the American Pain Society today released joint guidelines on diagnosing and treating low back pain.
One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests.
Bristol researchers have identified a heart protection mechanism in mice that surgeons and cardiologists may be able to exploit to improve treatments for patients in future.
Ontario Liberals will take another step forward in its battle against cancer by covering prostate specific antigen (PSA) tests for men over the age of 50, said Health Minister George Smitherman from the Columbus Centre Fitness Club.